Werewolf Therapeutics jumps 12% as RA Capital raises stake

Shares of Werewolf Therapeutics are up 12% afterhours at $2.50 per share. In a 13D/A filing, RA Capital has disclosed that it is raising its stake in the stock to 18.0% from 14.6%, also stating: "In addition, consistent with their investment purpose, the Reporting Persons may engage in communications with persons associated with the Issuer, including shareholders of the Issuer, officers of the Issuer, members of the board of directors of the Issuer, and/or or other third parties, to discuss matters regarding the Issuer, including but not limited to its operations, strategic direction, governance or capitalization, and potential business combinations or dispositions involving the Issuer or certain of its businesses. Dr. Derek DiRocco, a Partner of RA Capital, currently serves as a director of the Issuer and therefore will engage in regular discussions with the Issuer’s board of directors and management as part of his duties as a director."